{"id":"NCT00386607","sponsor":"Novartis","briefTitle":"A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide.","officialTitle":"A 54-week, Open-label, Multicenter Study to Assess the Long-term Safety and Tolerability of the Combination of Aliskiren 300 mg /Valsartan 320 mg in Patients With Essential Hypertension Followed by a 26 Week Open-label Extension to Assess the Long-term Safety and Tolerability of the Triple Combination of Aliskiren/Valsartan/Hydrochlorothiazide(HCTZ)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-10","primaryCompletion":"2008-07","completion":"2008-07","firstPosted":"2006-10-11","resultsPosted":"2011-05-10","lastUpdate":"2014-02-10"},"enrollment":601,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hypertension"],"interventions":[{"type":"DRUG","name":"Aliskiren","otherNames":[]},{"type":"DRUG","name":"Valsartan","otherNames":[]},{"type":"DRUG","name":"Hydrochlorothiazide (HCTZ)","otherNames":[]}],"arms":[{"label":"Core Treatment","type":"EXPERIMENTAL"},{"label":"Extension Treatment","type":"EXPERIMENTAL"}],"summary":"Assessment of the long-term safety and tolerability of the combination of aliskiren and valsartan (300 mg/ 320 mg) in patients with high blood pressure,followed by assessment of long-term safety and tolerability of the combination of aliskiren/valsartan/Hydrochlorothiazide(HCTZ).","primaryOutcome":{"measure":"Overall Percentage of Patients With Adverse Events","timeFrame":"Month 12","effectByArm":[{"arm":"Core Treatment- Aliskiren/Valsartan & Aliskiren/Valsartan/HCTZ","deltaMin":76.2,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":4},"locations":{"siteCount":4,"countries":["United States","Canada","Germany","Netherlands"]},"refs":{"pmids":["21062137"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":601},"commonTop":["Dizziness","Nasopharyngitis","Headache","Diarrhoea","Upper respiratory tract infection"]}}